Pub Date : 2019-03-04DOI: 10.4172/2167-0420-c5-019
O. Tillo
{"title":"Overview of breast reconstruction options and latest advances and controversies","authors":"O. Tillo","doi":"10.4172/2167-0420-c5-019","DOIUrl":"https://doi.org/10.4172/2167-0420-c5-019","url":null,"abstract":"","PeriodicalId":17626,"journal":{"name":"Journal of Womens Health Care","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91280695","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-02-04DOI: 10.4172/2167-0420-C4-016
pS Yamini Sudha Lakshmip
{"title":"Complementary Alternate Medicine (CAM) therapy against biomarker of oral and breast cancer in women treated with conventional medicine","authors":"pS Yamini Sudha Lakshmip","doi":"10.4172/2167-0420-C4-016","DOIUrl":"https://doi.org/10.4172/2167-0420-C4-016","url":null,"abstract":"","PeriodicalId":17626,"journal":{"name":"Journal of Womens Health Care","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87588855","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-02-04DOI: 10.4172/2167-0420-c4-017
pJohn PalacioCardonap
{"title":"The treatment of acne as a strategy to improve contraceptive adherence in Colombian young women","authors":"pJohn PalacioCardonap","doi":"10.4172/2167-0420-c4-017","DOIUrl":"https://doi.org/10.4172/2167-0420-c4-017","url":null,"abstract":"","PeriodicalId":17626,"journal":{"name":"Journal of Womens Health Care","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80555572","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-02-04DOI: 10.4172/2167-0420-C4-018
pEmiley Watsonp
{"title":"Bacteriocin production by Lactobacillus crispatus vaginal isolates","authors":"pEmiley Watsonp","doi":"10.4172/2167-0420-C4-018","DOIUrl":"https://doi.org/10.4172/2167-0420-C4-018","url":null,"abstract":"","PeriodicalId":17626,"journal":{"name":"Journal of Womens Health Care","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89932255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2018-11-30DOI: 10.4172/2167-0420-c2-012
pKatarzyna Stefanska Marek Niedoszytko Przemyslaw Adamski Dor Zamkowska, Krzysztof Preisp
{"title":"PIH as a complication of pregnancy in the patient with rare disease mastocytosis","authors":"pKatarzyna Stefanska Marek Niedoszytko Przemyslaw Adamski Dor Zamkowska, Krzysztof Preisp","doi":"10.4172/2167-0420-c2-012","DOIUrl":"https://doi.org/10.4172/2167-0420-c2-012","url":null,"abstract":"","PeriodicalId":17626,"journal":{"name":"Journal of Womens Health Care","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74654207","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2018-01-01Epub Date: 2018-02-12DOI: 10.4172/2167-0420.1000e132
Rayhan A Lal, Marina Basina
Hirsutism is a fairly common diagnosis affecting 10% of women [1]. Mild symptoms are not always brought to medical attention, but severe cases, especially in menopause that are associated with hyperandrogenism, require evaluation and treatment. We present a case of postmenopausal hirsutism to demonstrate the diagnostic and therapeutic challenges seen in practice. A 55 year-old postmenopausal woman with history of multi nodular goiter, autoimmune hepatitis, lupus erythematosus panniculitis, diabetes and acid reflux presents with restlessness, increased libido, hair loss, worsening hirsutism, and 25-pound weight loss over 2 months. Medications include azathioprine, metformin, lisinopril, and omeprazole. Physical examination revealed BMI of 34 kg/m2, severe hirsutism (FerrimanGallwey score of 18), receding hairline, goiter, prior scarring from abdominal procedures and normal external genitalia without clitoromegaly. Labs included TSH 1.05 (normal 0.5-4.5), hemoglobin A1c of 6.1% (normal <5.7), LH 29.8 mIU/mL (normal 20-70), FSH 38.5 mIU/mL (normal 30-120), total testosterone 94.7 ng/dL (normal 7-40), free testosterone 2.2 ng/dL (normal <1), estradiol 28.5 pg/mL (normal <20), DHEA-S 25.2 μg/dL (normal 15-200), cortisol 7.1 μg/dL (normal 7-20) and ACTH 15 pg/mL (10-60 pg/mL). Screening tests for occult Cushing’s syndrome and pheochromoctyoma were negative.
{"title":"Postmenopausal Hyperandrogenism.","authors":"Rayhan A Lal, Marina Basina","doi":"10.4172/2167-0420.1000e132","DOIUrl":"https://doi.org/10.4172/2167-0420.1000e132","url":null,"abstract":"Hirsutism is a fairly common diagnosis affecting 10% of women [1]. Mild symptoms are not always brought to medical attention, but severe cases, especially in menopause that are associated with hyperandrogenism, require evaluation and treatment. We present a case of postmenopausal hirsutism to demonstrate the diagnostic and therapeutic challenges seen in practice. A 55 year-old postmenopausal woman with history of multi nodular goiter, autoimmune hepatitis, lupus erythematosus panniculitis, diabetes and acid reflux presents with restlessness, increased libido, hair loss, worsening hirsutism, and 25-pound weight loss over 2 months. Medications include azathioprine, metformin, lisinopril, and omeprazole. Physical examination revealed BMI of 34 kg/m2, severe hirsutism (FerrimanGallwey score of 18), receding hairline, goiter, prior scarring from abdominal procedures and normal external genitalia without clitoromegaly. Labs included TSH 1.05 (normal 0.5-4.5), hemoglobin A1c of 6.1% (normal <5.7), LH 29.8 mIU/mL (normal 20-70), FSH 38.5 mIU/mL (normal 30-120), total testosterone 94.7 ng/dL (normal 7-40), free testosterone 2.2 ng/dL (normal <1), estradiol 28.5 pg/mL (normal <20), DHEA-S 25.2 μg/dL (normal 15-200), cortisol 7.1 μg/dL (normal 7-20) and ACTH 15 pg/mL (10-60 pg/mL). Screening tests for occult Cushing’s syndrome and pheochromoctyoma were negative.","PeriodicalId":17626,"journal":{"name":"Journal of Womens Health Care","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/33/c5/nihms-1055326.PMC7153778.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37831094","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2018-01-01DOI: 10.4172/2167-0420-c5-021
U. Shrivastava
Background: Polycystic ovary syndrome is one of the most common causes of anovulatory sub-fertility in women of reproductive age-group. The therapeutic procedure for women with polycystic ovary syndrome wanting to be pregnant is ovulation induction. Different medicines have been used based on individual signs and symptoms as the most effective one is not clearly evident. Clomiphene citrate and letrozole are the most common drugs used alone or in combination with metformin to achieve pregnancy in women with polycystic ovary syndrome. In this study, the efficacy of combined clomiphene citrate-metformin is compared with letrozole-metformin in achieving pregnancy among women with polycystic ovary syndrome. Methods: A retrospective study was performed among women with polycystic ovary syndrome attending Infertility Center, Kathmandu, Nepal from January 2013 to December 2015. Samples were randomly selected from list of the record in the treatment centre within the study duration. Total 146 cases with 73 each in clomiphene citratemetformin group and letrozole-metformin group were entered into the analysis. Participants had received metformin in combination with either clomiphene citrate (100 mg) or letrozole (2.5 mg) from day 3 to 5 of their menstrual cycle. Odds ratio, with confidence interval set at 95%, was calculated to compare the efficacy between two groups. Results: The pregnancy rate of clomiphene citrate-metformin was 54.79% and letrozole-metformin was 34.25%. Patients treated with clomiphene citrate-metformin were two times more likely to get pregnant [OR: 2.33, 95% CI: 1.19 – 4.54] than those treated with letrozole-metformin. Miscarriage rate was not found to be statistically significant. Conclusion: Clomiphene citrate in combination with metformin is more likely to be effective than letrozole with metformin in achieving pregnancy.
{"title":"Combined clomiphene citrate-metformin versus letrozole-metformin in achieving pregnancy among women: Polycystic ovary syndrome","authors":"U. Shrivastava","doi":"10.4172/2167-0420-c5-021","DOIUrl":"https://doi.org/10.4172/2167-0420-c5-021","url":null,"abstract":"Background: Polycystic ovary syndrome is one of the most common causes of anovulatory sub-fertility in women of reproductive age-group. The therapeutic procedure for women with polycystic ovary syndrome wanting to be pregnant is ovulation induction. Different medicines have been used based on individual signs and symptoms as the most effective one is not clearly evident. Clomiphene citrate and letrozole are the most common drugs used alone or in combination with metformin to achieve pregnancy in women with polycystic ovary syndrome. In this study, the efficacy of combined clomiphene citrate-metformin is compared with letrozole-metformin in achieving pregnancy among women with polycystic ovary syndrome. Methods: A retrospective study was performed among women with polycystic ovary syndrome attending Infertility Center, Kathmandu, Nepal from January 2013 to December 2015. Samples were randomly selected from list of the record in the treatment centre within the study duration. Total 146 cases with 73 each in clomiphene citratemetformin group and letrozole-metformin group were entered into the analysis. Participants had received metformin in combination with either clomiphene citrate (100 mg) or letrozole (2.5 mg) from day 3 to 5 of their menstrual cycle. Odds ratio, with confidence interval set at 95%, was calculated to compare the efficacy between two groups. Results: The pregnancy rate of clomiphene citrate-metformin was 54.79% and letrozole-metformin was 34.25%. Patients treated with clomiphene citrate-metformin were two times more likely to get pregnant [OR: 2.33, 95% CI: 1.19 – 4.54] than those treated with letrozole-metformin. Miscarriage rate was not found to be statistically significant. Conclusion: Clomiphene citrate in combination with metformin is more likely to be effective than letrozole with metformin in achieving pregnancy.","PeriodicalId":17626,"journal":{"name":"Journal of Womens Health Care","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84708995","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2018-01-01DOI: 10.4172/2167-0420-C3-013
pPanagiotis Christopoulosp
{"title":"Aesthetic gynecology: A mini-overview","authors":"pPanagiotis Christopoulosp","doi":"10.4172/2167-0420-C3-013","DOIUrl":"https://doi.org/10.4172/2167-0420-C3-013","url":null,"abstract":"","PeriodicalId":17626,"journal":{"name":"Journal of Womens Health Care","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81619061","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2018-01-01DOI: 10.4172/2167-0420-c3-015
Amalia Daleziou
{"title":"Ten golden rules for future parents","authors":"Amalia Daleziou","doi":"10.4172/2167-0420-c3-015","DOIUrl":"https://doi.org/10.4172/2167-0420-c3-015","url":null,"abstract":"","PeriodicalId":17626,"journal":{"name":"Journal of Womens Health Care","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75558058","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2018-01-01DOI: 10.4172/2167-0420-c2-010
M. Punyanitya
{"title":"The ultimate quantified self: A digital physical examination for precision medicine","authors":"M. Punyanitya","doi":"10.4172/2167-0420-c2-010","DOIUrl":"https://doi.org/10.4172/2167-0420-c2-010","url":null,"abstract":"","PeriodicalId":17626,"journal":{"name":"Journal of Womens Health Care","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86712377","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：